RSS
drug metabolism and pharmacokinetics (DMPK)
Sygnature Discovery announces next stage of expansion with new facility at Alderley Park
Independent provider of integrated drug discovery and pre-clinical services and expertise, Sygnature Discovery, has announced the next stage of its expansion plans with the addition of a new facility at Alderley Park. Read more
Citoxlab acquires specialist CRO in drug transporter research and drug-drug interactions
Citoxlab Group, a non-clinical contract research organisation (CRO), has entered into a definitive agreement to acquire a CRO that specialises in drug transporter studies and the assessment of drug-drug interactions (DDI), Solvo Biotechnology. Read more
XenoGesis invests in LC-MS/MS machine
A significant investment has been made by drug metabolism and pharmacokinetics (DMPK) business XenoGesis in a brand new LC-MS/MS machine, bringing the company's total number of mass spec machines at its BioCity base to three. Read more
